Qing-Nan Tang

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 150 citations

Medicine, Oncology, Radiation Oncology +14

Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study

Qiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang et al. · Cancer Research and Treatment · 2017 · 46 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu et al. · BMC Cancer · 2019 · 44 citations · Full text

Medicine, Oncology, Chemotherapy +16

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance

Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu et al. · Cancer Research and Treatment · 2019 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +16

<p>The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study</p>

Xiao-Yun Li, Xue-Song Sun, Sai-Lan Liu et al. · Cancer Management and Research · 2019 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +11